Posts Tagged: gsk

CAFC Again Says Teva Induced Infringement on Carvedilol, Assures Holding Narrowly Applies

The U.S. Court of Appeals for the Federal Circuit (CAFC) on Thursday underscored its October 2020 ruling that generic company, Teva Pharmaceuticals, was liable for induced infringement …
By Eileen McDermott
2 months ago 0

Federal Circuit Says Teva Induced Infringement of GSK Patent on Congestive Heart Failure Drug

In GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion …
By Rebecca Tapscott
1 year ago 0

Why NIH/Industry Partnerships Matter: Ask an HIV patient

Those who believe that patents aren't important or that companies would undertake the rigors of commercial development with only non-exclusive licenses don't understand the realities facing innovators …
By Joseph Allen
4 years ago 1

Pharma Scandals: Bribery, Insider Trading and Paula Deen

The summer may be in full swing, but the torrent pace of news and interesting developments has not subsided at all. Hot days simply yield hot stories. …
By Ed Silverman
8 years ago 0

Pharma Law and Business – A Monthly Roundup for January 2013

Not surprisingly, 2013 began with a predictable rush of interesting news. So here are some of the most recent highlights, from court rulings and medical study findings to …
By Ed Silverman
9 years ago 1

Tafas v. Dudas/Doll – 5 Years Later But Still Very Pertinent

Although such Final Rules were widely criticized by most companies in the United States, a sole individual, Dr. Triantafyllos Tafas, a co-inventor of a computerized automated microscope, …

Patent Business: Deals, Acquisitions & Licenses July 2012

This deal will give GSK exclusive rights to BENLYSTA, which is a human monoclonal antibody that inhibits B-cell activating factor (BAFF) approved for treatment of systemic lupus …
By Gene Quinn
9 years ago 0

Licensing Executives Society Announces 2010 Deals of Distinction™ Awards

In May 2009, Genzyme Corporation acquired the worldwide rights to a potential breakthrough treatment for Multiple Sclerosis (MS) along with three marketed oncology products from Bayer Healthcare Pharmaceuticals. …
By Gene Quinn
11 years ago 0

Tafas and GlaxoSmithKline Awarded Jefferson Medal by NJIPLA

Tafas and GSK were recognized with this prestigious award for their successful legal challenge to the claims and continuations rules made final in 2007 by the United States …
By Gene Quinn
11 years ago 2

JUST IN: Federal Circuit Denies Vacatur in USPTO Rules Case

Earlier today the Chief Judge Paul Michel of the United States Court of Appeals for the Federal Circuit issued an Order declaring the pending appeal of Dr. …
By Gene Quinn
12 years ago 5

Tafas Objects to Vacatur in Claims and Continuations Appeal

Late this evening attorneys representing Dr. Triantafyllos Tafas filed a Reply to Motion for Dismissal of Appeal and Request for Remand. In this filing Tafas points out …
By Gene Quinn
12 years ago 1

USPTO Agrees to Withdraw Claims & Continuations Rules

PRESS RELEASE: GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO’s motion …
By Gene Quinn
12 years ago 4

Federal Circuit to Rehear Tafas and GSK v. Doll

On Monday, July 6, 2009, the United States Court of Appeals for the Federal Circuit (minus Judge Lourie who did not participate in the poll of judges) decided to …
By Gene Quinn
12 years ago 5

Tafas Requests Rehearing of Claims & Continuations Ruling

As soon as I learned that the date for requesting rehearing or en banc consideration of the Federal Circuit ruling in the GSK and Tafas appeal of …
By Gene Quinn
12 years ago 3

Federal Circuit Grants USPTO, GSK and Tafas More Time

Last Thursday I wrote regarding the USPTO, GlaxoSmithKline and Dr. Tafas jointly requesting an extension of time within which to either request reconsideration or rehearing en banc …
By Gene Quinn
12 years ago 6